SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Title
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Authors
Keywords
SARS-CoV-2 variants, COVID-19, neutralizing antibodies, vaccines, monoclonal antibodies, B.1.1.7, Moderna, Novavax
Journal
Cell Host & Microbe
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-07
DOI
10.1016/j.chom.2021.03.002

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started